This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Beauty brand Foreo safeguards product design in China despite setback in patent suit

By MLex Staff ( February 28, 2025, 04:43 GMT | Insight) -- Swedish beauty-tech company Foreo has scored a landmark legal victory in China, successfully leveraging competition laws to safeguard the innovative design of its flagship skincare products. The company was ultimately awarded $206,000 in damages from several Chinese infringers for their unauthorized use of Foreo's influential design features. The court win came after an earlier setback suffered by Foreo in pursuing the case under patent laws.Swedish beauty-tech company Foreo has scored a landmark legal victory in China, successfully leveraging competition laws to safeguard the innovative design of its flagship skincare products. The company was ultimately awarded 1.5 million yuan ($206,000) in damages from several Chinese infringers for their unauthorized use of Foreo's influential design features....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections